Product category:
Microplates/microarrays and readers
News Release from: Cellomics Europe | Subject: Cytotoxicity 1 assay
Edited by the Laboratorytalk Editorial
Team on 14 January 2002
Hallmark indicators of drug toxicity
The multiparameter Cytotoxicity 1 assay is the latest in Cellomics's series of HitKits, to quantify multiple hallmark indicators of drug toxicity in cells
The new multiparameter Cytotoxicity 1 assay allows users to simultaneously quantify four hallmarks of cytotoxicity: nuclear size/ morphology, cell membrane permeability, lysosomal mass-pH, and cell density (number of cells per field) The multiplexed measurements provided by the novel Cytotoxicity assay are performed in cultured cells and have been optimised for use with the fully automated ArrayScan high content screening system
This article was originally published on Laboratorytalk on 11 Oct 2001 at 8.00am (UK)
Related stories
Automation for cell-based drug discovery
The ArrayScan HCS system from Cellomics is a proprietary drug discovery instrument that performs automated measurement and analysis of spatial and temporal events in cells
Access to data from over 1.8 million papers
The torrent of data now being produced by post-genomic research requires sophisticated new bioinformatics tools to assist in understanding what it all means
The assay, which includes calibration wells, enables quantification of the effects of testing compounds on a cell-by-cell basis when used with the ArrayScan HCS system.
The Cytotoxicity assay represents a new class of high value assays from Cellomics because it is broadly applicable throughout the early drug discovery process and in all therapeutic disciplines.
Many pharmaceutical companies have adopted a philosophy of killing 'unacceptable' drugs earlier in the discovery process so as to improve attrition rates, as is evidenced by the increasing trend toward in vitro toxicity assays.
These typically occur further upstream in the discovery process than traditional animal studies.
The ArrayScan HCS system, a proprietary system developed by Cellomics, performs automated acquisition, analysis, and presentation of information on multiple spatial and temporal events in individual cells.
ArrayScan was developed to provide reliable insight into the efficacy and toxicity of drug candidates.
Measurement of these complex cellular responses provides researchers with additional knowledge that can be critical to accurately determine which targets to investigate and which lead compounds to pursue.
• Cellomics Europe: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
